Full-Time
Principal Human Resources Information Management Architect
Reporting and Analytics
Updated on 7/21/2026
Revvity
1,001-5,000 employees
Translational multi-omics and diagnostics provider
No salary listed
Remote in India
Remote
Remote within India.
 Data & Analytics (1) |
|---|
Get referred to Revvity
Find people who can refer or advise you
- Fluent English
- Ability to work in a diverse, fast-paced environment and effectively collaborate across teams.
- Highly developed problem-solving skills.
- Excellent verbal and written communication skills with ability to effectively communicate technical information to both technical and non-technical stakeholders.
- Understanding of data governance principles and best practices
- Strong understanding of Workday functionality and structure HCM, Report Writer, EIBs
- Advanced proficiency in Microsoft Excel
- Bachelor's Degree in computer science, HR, IT, or Business
- 4+ years of hands-on experience in Workday reporting tools and module including advance reporting and analytics, dashboards, calculated fields, and configuration experience (mandatory)
- 5+ years of processional experience working with data, reporting and analytics.
- Ability to develop and execute comprehensive reporting strategies aligned with business objectives and regulatory requirements.
- Ability to analyze complex data sets, identify trends, patterns and insights and translate them into recommendations for stakeholders.
- Experience managing reporting projects from conception to completion, including requirements gathering, planning, execution and documentation.
- Excellent analytical and technical skills with great attention to detail
- Knowledge of human resources processes and best practices
- Ability to maintain confidentiality and data accuracy when handling employee information.
- Analyze, design, and build new custom reports, dashboards, surveys as required using standard Workday reporting functionality (Report Writer, Calculated Fields, BIRT)
- Identify areas of opportunity for automation and globalization, and provide high-quality analytics, reports, surveys, and dashboards to our leadership teams.
- Collaborate with stakeholders and translate business requirements into technical specifications, design, develop, test, and deploy in production.
- Manage the Workday upgrade and changes.
- Help maintain and support Workday security framework for the organization and look for opportunities to streamline the security roles and role assignments.
- Work with project teams on various Workday implementation and optimization projects
- Document and build Standard Operating Procedures (SOPs) for the existing and new processes.
- Evaluate and update the Workday reporting catalogue to meet business requirements and establishing a program that builds reporting and analytics capability within the HR team.
- Support audit and compliance efforts and troubleshoot system and data issues.
- Look for opportunities to optimize and streamline the processes and partner with HR leaders in implementing changes.
- Support the business and reporting and analytics globally on Workday technology specific matters on a day-to-day basis.
- Assist with escalated inquiries regarding data, reporting, and dashboards.
- Train users on Workday reporting functions and available reports
- Troubleshooting product configuration to resolve or provide optimal product configuration to meet customer business requirements.
- Help develop reporting governance structure –naming convention, tagging, etc.
- Work on acquisitions to integrate new company from a technology standpoint.
- Develop a robust library of test scenarios for use when rolling out new processes or features
- Advise stakeholders on best practices.
- Work with integration and cross-functional teams to resolve integration and data issues.
- Collaborate within the team in developing new processes as and when there is a dependency on multiple modules within Workday.
- Create and update One Point Lessons (OPL) that can be published as a reference document to initiate tasks or processes
- Workday Birt and composite reporting Experience
Revvity provides health science solutions that span the full journey from discovery to development and from diagnosis to cure. It offers translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis, and informatics, all delivered as integrated workflows and expert services. The company differentiates itself with an end-to-end platform that combines omics, imaging, biomarkers, and data analytics with specialized support to speed development. Its goal is to turn previously impossible healthcare outcomes into achievable results, advancing discovery, development, diagnosis and patient care.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Waltham, Massachusetts
Founded
2023
Get referred to Revvity
Find people who can refer or advise you
Simplify's Take
What believers are saying
- AI in life science analytics market grows 10.8% CAGR through 2035
- Mercury DRUG-seq distribution expands multi-omics capabilities for drug discovery
- Unusual items masking $95M profit suggest stronger underlying earnings potential
What critics are saying
- China IDX divestiture failure by 2027 could trap $200M loss amid cash pressures
- Software revenue 20% Q2 decline risks derailing full-year guidance targets
- EPS decline over 12 months threatens investor confidence despite adjusted beats
What makes Revvity unique
- Signals AI integrates Anthropic Claude via MCP for natural language R&D access
- Strategic divestiture of China immunodiagnostics unit improves organic growth by 100bps
- Comprehensive testosterone testing portfolio replaces complex equilibrium dialysis methods
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Company Match
Employee Stock Purchase Plan
Growth & Insights and Company News
6 month growth
↑ 5%1 year growth
↑ 5%2 year growth
↑ 4%Revvity has launched Signals BioDesign, a cloud-native molecular cloning solution designed to streamline biologics research workflows for biotech and pharmaceutical R&D teams. The platform supports core cloning methodologies including Golden Gate, Gibson assembly, restriction/ligation, primer design and Sanger sequencing analysis. The solution enables high-throughput combinatorial cloning for up to 1,000 constructs whilst maintaining workflow simplicity. As the only cloud-native molecular cloning tool integrated with the Signals One platform, it connects design with existing bioregistration and experiment capture in a unified ecosystem. The cloud architecture provides real-time team collaboration, centralised bio-sequence libraries and granular access controls. Revvity will introduce Signals BioDesign at the Bio-IT World Conference & Expo in Boston from 19–21 May.
Revvity Omni - now available from John Morris Group. New Brand Announcement John Morris Group appointed distributor for Revvity Omni in Australia and New Zealand. John Morris Group | New Distribution Partnership | Australia & New Zealand John Morris Group is pleased to announce its appointment as an authorised distributor for the Revvity Omni range of homogenisers and sample preparation solutions across Australia and New Zealand. Supported applications. Revvity Omni is internationally respected for its expertise in sample disruption and homogenisation, with proven solutions supporting a broad range of industries and disciplines: Molecular Biology & Genomics Food & Agricultural Testing Environmental Analysis Pharmaceuticals & Biotechnology Clinical Research Product range. The Revvity Omni range, now available to order through John Morris Group, includes: Bead Mill Homogenisers, Manual and Programmable Fast, reliable bead-beating technology for consistent, reproducible sample disruption across biological, environmental, and food matrices. Models include the Bead Ruptor 4, 12, 24, Elite, and 96+, covering sample volumes from 0.5 mL to 50 mL. Rotor-Stator Homogenisers High-shear homogenisers for rapid disruption of tissue, cells, and tough sample types. The range includes the Tissue Homogenizer (TH220), Tissue Master (TM125), Macro ES, Mixer, and General Lab Homogenizer 850, with a broad selection of probe sizes and chamber accessories for small to large volumes. Automated Homogenisation Systems with Integrated Liquid Handling Streamline high-throughput sample preparation with automation and precision liquid handling in a single integrated platform. Ideal for laboratories processing large sample volumes requiring consistent, walk-away results. Tubes, Bead Kits & Consumables A comprehensive range of prefilled bead kits (0.1 mm to 6.5 mm in glass, ceramic, garnet and stainless steel), bulk bead media, sample tubes (0.5 mL to 50 mL), 96-well deep well plates, and Omni Tips, all optimised for use with the Revvity Omni instrument range. Local support across Australia & New Zealand. Through this distribution arrangement, customers will benefit from the full John Morris Group service offering: Local Technical Support Application Guidance Product Demonstrations Quotations After-Sales Service John Morris Group has a long history of supporting scientific and research customers with high-quality instrumentation and responsive local service. The addition of the Revvity Omni range further strengthens the company's offering in sample preparation and workflow automation. About Revvity Omni Revvity Omni delivers globally recognised expertise in sample disruption and homogenisation, trusted by laboratories worldwide for performance, reliability, and innovation in sample preparation. About John Morris Group Founded in 1952, John Morris Group has been a trusted supplier of scientific, environmental, and industrial instrumentation in Australia and New Zealand for over 70 years, with offices nationwide and a large team of qualified service engineers. This new partnership expands John Morris Group's laboratory portfolio and strengthens local access to Omni's globally recognised sample preparation technologies, spanning bead mill and rotor-stator homogenisation and automated liquid handling workflows. Customers across Australia and New Zealand can now engage directly with John Morris Group for product selection, quotations, demonstrations, and ongoing local support. Interested in Revvity Omni? Speak with its team for product selection support, a demonstration, or a quote. John Morris Group is ready to help you find the right solution for your laboratory. John Morris Group. Australia & New Zealand's trusted partner for scientific instruments, laboratory equipment, and technical solutions since 1962. March 6, 2026
Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026. Revvity, Inc. announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows. Making their debut at the conference in Boston, February 7-11, are the Opera Phenix OptIQ(TM) high-content screening system, the EnVision Nexus(TM) One multimode plate reader, and the AssayMate(TM) workstation, alongside other recently introduced solutions spanning sample preparation, screening, advanced imaging, and lab automation. At booth #612, Revvity will showcase an expanded portfolio of integrated workflow solutions designed to support discovery programs from early screening through data-driven decision making. Solutions debuting at SLAS2026 include: * Opera Phenix OptIQ high-content screening system: Designed to reduce bottlenecks in phenotypic screening and advanced cellular analysis, this system enables quantitative imaging across complex biological models, including 3D organoids and organ-on-chip systems. Peak camera quantum efficiency has increased from 60 % to 95 %, improving image sensitivity and data quality, and the system is equipped with Phenologic.AI image analysis software that now includes new classification capabilities, such as cell cycle analysis, expanding beyond its previous focus on segmentation. Laser-based autofocus has been enhanced to better support multi-layer sample carriers, and a new Harmony(TM) software building block enables detection of organoids in brightfield image stacks. * EnVision Nexus One multimode plate reader: The newest addition to the EnVision Nexus family, the EnVision Nexus One delivers the trusted sensitivity and reliability of the Envision Nexus platform in a streamlined single-detector configuration optimized for high-throughput screening environments. Designed to simplify automation and integration while supporting evolving assay needs, the system provides enhanced sensitivity across TRF, Alpha, and luminescence detection. The EnVision Nexus One is powered by intuitive Kaleido(TM) software with 21 CFR Part 11 compliance tools and offers flexible configuration options to support a wide range of laboratory workflows. * AssayMate workstation: The compact, benchtop AssayMate liquid handler delivers intelligent automation performance for labs of any size. It supports a wide volume range of 3-1000 μL without requiring head changes, using a fixed 8-channel head and gripper configuration. Intelligent features such as pressure-based liquid level detection (PLLD) and built-in workflow error handling - including detection of missing plate lids - enable reliable operation and quick experiment resumption. A reconfigurable recessed deck accommodates optional modules such as heater shakers, heater coolers, and magnetic blocks, while AssayPREP(TM) software provides a user-friendly, drag-and-drop interface that requires minimal training. SLAS2026 marks a key milestone for Revvity with the introduction of new platforms that support the evolving needs of discovery labs, These launches integrate automation, trusted assay technologies, and AI-driven imaging to help customers accelerate results while maintaining data quality." Kevin Quick, Vice President, Platforms, Revvity
Revvity has launched multiple discovery platforms at SLAS2026 in Boston, designed to accelerate high-throughput drug discovery workflows. The new products include the Opera Phenix OptIQ high-content screening system, EnVision Nexus One multimode plate reader, and AssayMate workstation. The Opera Phenix OptIQ features improved camera quantum efficiency from 60% to 95% and enhanced Phenologic.AI image analysis software with new classification capabilities. The EnVision Nexus One offers a streamlined single-detector configuration optimised for high-throughput screening. The compact AssayMate workstation delivers intelligent automation with a volume range of 3–1000 µL without requiring head changes. Revvity, which reported 2025 revenue of $2.9 billion, serves pharmaceutical, biotech, and diagnostic lab customers across more than 160 countries.
Revvity reported fourth quarter 2025 revenue of $772 million, up 6% with 4% organic growth, and adjusted earnings per share from continuing operations of $1.70, compared to $1.42 a year earlier. GAAP EPS was $0.87, up from $0.78. For full year 2025, revenue reached $2.86 billion, up from $2.76 billion in 2024. Adjusted EPS from continuing operations was $5.06, compared to $4.90 in 2024, whilst GAAP EPS was $2.07. The Life Sciences segment generated $382 million in fourth quarter revenue with 2% growth, and $1.43 billion for the full year with 2% organic growth. CEO Prahlad Singh said results exceeded expectations and the company is well-positioned following recent portfolio transformation. The company has initiated full year 2026 guidance.